| P50 | author | Alessandro Ceschi | Q82588818 |
| P2093 | author name string | Hugo Kupferschmidt | |
| | Gerd A Kullak-Ublick | |
| | Christine Rauber-Lüthy | |
| | Dieter Genser | |
| | Dagmar Prasa | |
| | Hans-Jürgen Reinecke | |
| | Marianne Meli | |
| | Uwe Stedtler | |
| | Elke Färber | |
| | Petra Hoffmann-Walbeck | |
| P2860 | cites work | Toxicology and overdose of atypical antipsychotics | Q28265894 |
| | Abstracts of the XXVIII International Congress of the European Association of Poison Centres and Clinical Toxicologists. May 6-9, 2008. Seville, Spain | Q28284615 |
| | 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report | Q30583507 |
| | Antipsychotics in children and adolescents | Q33608999 |
| | Olanzapine overdose in an 18-month-old child | Q33814167 |
| | Paediatric uses of atypical antipsychotics | Q34182013 |
| | The pharmacology and toxicology of atypical antipsychotic agents | Q34235349 |
| | Preventing medication overdoses in young children: an opportunity for harm elimination. | Q34629060 |
| | Poisoning severity score. Grading of acute poisoning | Q34749010 |
| | Children's behavior and physiology and how it affects exposure to environmental contaminants | Q35732583 |
| | Atypical antipsychotics in the treatment of children and adolescents: clinical applications. | Q35754262 |
| | Are 1 or 2 dangerous? Clozapine and olanzapine exposure in toddlers | Q35896860 |
| | Second-generation antipsychotic medications in children and adolescents | Q36009445 |
| | Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer? | Q36084584 |
| | Antipsychotic poisoning in young children: a systematic review | Q36289363 |
| | Overdoses and ingestions of second-generation antipsychotics in children and adolescents | Q36354290 |
| | Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. | Q36946346 |
| | A systematic review of cardiovascular effects after atypical antipsychotic medication overdose | Q37381004 |
| | Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns | Q37495011 |
| | Risperidone overdose causes extrapyramidal effects but not cardiac toxicity | Q37772741 |
| | Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations | Q37815811 |
| | Antipsychotic drug toxicology in children | Q37852719 |
| | Review on the current use of antipsychotic drugs in children and adolescents. | Q37902788 |
| | The growing impact of pediatric pharmaceutical poisoning | Q43707797 |
| | Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management | Q46830215 |
| | Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics | Q50278391 |
| | Poisoning-related visits to emergency departments in the United States, 1993-1996. | Q50655675 |
| | Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study. | Q51389910 |
| | Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents | Q58822795 |
| | Medication overdoses leading to emergency department visits among children | Q64132311 |
| | Understanding the limitations of retrospective analyses of poison center data | Q80419048 |
| | New drug therapies for diseases in children: from atypical antipsychotics to antivenom for snakebites | Q81596194 |
| | Poisoning in young children | Q84905231 |
| P433 | issue | 6 | |
| P921 | main subject | poisoning | Q114953 |
| | multicenter clinical trial | Q6934595 |
| P304 | page(s) | 743-750 | |
| P577 | publication date | 2013-12-27 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Atypical antipsychotic poisoning in young children: a multicentre analysis of poisons centres data | |
| P478 | volume | 173 | |